
HCA Healthcare, Inc.
HCANYSECIK 860730HealthcareFiscal year ends Dec 31
Reports and events: 370 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-2316:31 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-044555 |
| 2024-02-2108:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-040747 |
| 2024-02-1617:03 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-016524 |
| 2024-01-3008:01 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-018748 |
| 2023-11-0907:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-274071 |
| 2023-10-2616:30 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-055641 |
| 2023-10-2408:27 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-261204 |
| 2023-08-0216:32 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-037237 |
| 2023-07-2707:55 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-195360 |
| 2023-07-1009:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-184269 |
| 2023-05-2616:35 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-155487 |
| 2023-05-0416:55 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-23-136049 |
| 2023-05-0209:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-131536 |
| 2023-04-2716:31 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-015314 |
| 2023-04-2116:29 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-110578 |
| 2023-04-2107:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-109258 |
| 2023-04-0616:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-094138 |
| 2023-03-1016:28 ET | DEF 14A | Proxy statement | 0001193125-23-067645 |
| 2023-02-1717:12 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-003234 |
| 2023-01-3016:36 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-23-019137 |
| 2023-01-2707:37 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-016833 |
| 2023-01-0417:02 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-23-001579 |
| 2022-12-1916:42 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-22-308372 |
| 2022-11-0116:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-020865 |
| 2022-10-2616:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-269593 |
| 2022-10-2107:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-266319 |
| 2022-08-1708:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-22-222847 |
| 2022-08-0116:31 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-013683 |
| 2022-07-2207:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-199606 |
| 2022-05-2620:28 ET | 8-K | 8.01 Other events | 0001193125-22-160031 |
| 2022-05-0316:31 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-007089 |
| 2022-04-2617:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-22-120439 |
| 2022-04-2208:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-114235 |
| 2022-04-1116:41 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-101742 |
| 2022-04-0716:44 ET | 8-K | 8.01 Other events | 0001193125-22-098964 |
| 2022-03-1116:25 ET | DEF 14A | Proxy statementPeriod 2022-04-21 | 0001193125-22-073436 |
| 2022-03-1021:56 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-22-070987 |
| 2022-03-0308:41 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-063719 |
| 2022-03-0216:43 ET | 8-K | 8.01 Other events | 0001193125-22-063063 |
| 2022-03-0209:28 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-062405 |
| 2022-02-1817:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001193125-22-046707 |
| 2022-01-2708:18 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-019075 |
| 2021-11-0116:30 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001193125-21-315476 |
| 2021-10-2716:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-309426 |
| 2021-10-2207:34 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-304715 |
| 2021-08-0216:37 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001193125-21-233345 |
| 2021-07-2708:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-225096 |
| 2021-07-2008:06 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-219158 |
| 2021-07-0121:42 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-21-205276 |
| 2021-06-2207:41 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-195711 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 11, 2026, 03:15 ET. Listed shows no prices and gives no investment advice.